Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing, and pathological activation. Platforms can help align a team of authoritative experts at home and abroad to provide accurate diagnoses and treatment plans. Treatment and management of treatment plans for the disease require individualized management, typically including drug therapy, rehabilitation, and regular follow-up visits.
In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many formerly difficult-to-treat neurological disorders have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to the timely schedule according to the changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of myeloma.
Platform services China International Medical Service System (CMS) provides a team of domestic and foreign experts with authority in the field of neural systems to provide the following services to patients: 4. Long-term follow-up: Establishment of a chronic disease management archive, continuous monitoring of disease changes and treatment effects. Follow-up with authoritative experts by medical advisors to authoritative experts after enrollment in the Membership Center; support for remote pre-diagnosis, translations and follow-up with authoritative experts.